7UD-27491-29122
3 vaccinations
4 coded responses
14 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 949 / CA
- Registered
- 2021-12-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-04-07
Dose 2 — Pfizer-BioNTech
-
2021-12-02
Registered in v-safe
-
2021-12-03
Dose 3 — Pfizer-BioNTech
- 2021-12-04
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Muscle or body aches, Abdominal painAdult check-in
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-17
-
2021-12-26
Survey response — day 21, dose 3MedDRA: Rhinorrhoea, Sneezing — Feeling: GoodFree text: Mild runny nose/sneezing.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Survey response — day 28, dose 3MedDRA: COVID-19, Headache, Pain, Rash, Rash pruritic, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Contracted covid. Runny nose, congestion, body aches, headache, skin rash/itchiness. All symptoms mild.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
- 2022-01-14
-
2022-03-04
Survey response — 3 months, dose 3MedDRA: Heart rate increased, Insomnia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Occasional faster heartbeat, elevated by about 20-30 BPM from resting heart rate, occurring mostly in evening, causing occasional insomniaMedDRA releases: 2024-11 · check-in free text available
- 2022-06-03
-
2022-12-03
Survey response — 12 months, dose 3MedDRA: Palpitations — Feeling: Good · Be unable to do your normal daily activitiesFree text: Onset of occasional palpitations in the months following second vaccination, especially at night. Symptoms lasted on and off for about 8 months and then disappeared.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | No |
| 2 | 2021-04-07 | Pfizer-BioNTech | No |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Mild runny nose/sneezing.
Release 10 — day 28, dose 3
Symptoms: Contracted covid. Runny nose, congestion, body aches, headache, skin rash/itchiness. All symptoms mild.
Release 11 — 3 months, dose 3
Symptoms: Occasional faster heartbeat, elevated by about 20-30 BPM from resting heart rate, occurring mostly in evening, causing occasional insomnia
Release 12 — 12 months, dose 3
Symptoms: Onset of occasional palpitations in the months following second vaccination, especially at night. Symptoms lasted on and off for about 8 months and then disappeared.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release